According to the World Health Organization, cancer remains one of the leading causes of death globally, with millions of new cases diagnosed each year. Blood-related disorders, including leukemia, lymphoma, multiple myeloma, and other hematological conditions, also represent a significant portion of complex medical care worldwide. The demand for experienced hematologists-oncologists continues to grow as populations age and diagnostic technologies improve. Many patients seek specialized centers that can provide comprehensive cancer and blood disorder management within structured healthcare systems.
Italy has a well-established public and private healthcare network that follows European Union medical standards and adheres to internationally recognized oncology and hematology guidelines. Clinical practice in Italy commonly aligns with recommendations from the European Society for Medical Oncology and the European Hematology Association. Italian hematologists-oncologists undergo structured medical training, including medical school, residency in hematology or oncology, and, in many cases, further subspecialty fellowships in areas such as bone marrow transplantation or targeted therapies.
Healthcare infrastructure in Italy includes tertiary university hospitals, research institutes, and comprehensive cancer centers located in cities such as Milan, Rome, Bologna, and Siena. These institutions often provide multidisciplinary tumor boards, integrating medical oncology, hematology, radiation oncology, surgery, pathology, and supportive care services. Costs for consultations and certain treatments may be comparatively accessible when viewed alongside some other Western countries, although expenses vary by provider and treatment plan.
Care is typically personalized, based on tumor biology, disease stage, genetic markers, and overall patient health. Emotional and psychological support services are frequently integrated into oncology departments, recognizing the impact of cancer diagnoses on patients and families. Overall, hematology-oncology care in Italy is delivered within a regulated, evidence-based framework focused on safety, clinical appropriateness, and patient-centered communication.
Dr. Michele Cavo, MD
Specialization: Hematology
Years of Experience: 30+ years
Dr. Michele Cavo is affiliated with Policlinico di Sant’Orsola-Malpighi in Bologna. His clinical focus includes multiple myeloma, plasma cell disorders, and stem cell transplantation. He has been involved in international clinical trials evaluating new therapeutic agents for hematologic malignancies. His practice emphasizes evidence-based treatment planning and risk-adapted therapy strategies.
Dr. Fabrizio Pane, MD
Specialization: Hematology
Years of Experience: 25+ years
Dr. Fabrizio Pane works at Azienda Ospedaliera Universitaria Federico II in Naples. His expertise includes chronic myeloid leukemia, myeloproliferative disorders, and translational research in hematologic diseases. He has contributed to guideline development in hematology and focuses on molecular monitoring and targeted therapy approaches.
Dr. Pier Luigi Zinzani, MD
Specialization: Hematology
Years of Experience: 25+ years
Dr. Pier Luigi Zinzani practices at Policlinico di Sant’Orsola-Malpighi in Bologna. He is known for his work in lymphomas and innovative treatment protocols, including immunotherapy and cellular therapies. His clinical approach integrates diagnostic precision with individualized care planning.
Dr. Paolo Corradini, MD
Specialization: Hematology and Bone Marrow Transplantation
Years of Experience: 25+ years
Dr. Paolo Corradini is affiliated with Istituto Nazionale dei Tumori in Milan. His focus includes hematologic malignancies and autologous and allogeneic stem cell transplantation. He participates in international collaborative research and emphasizes multidisciplinary evaluation before advanced therapeutic decisions.
Dr. Giampaolo Tortora, MD
Specialization: Medical Oncology
Years of Experience: 30+ years
Dr. Giampaolo Tortora practices at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome. His clinical interests include gastrointestinal cancers and translational oncology. He has experience integrating systemic therapies such as chemotherapy, immunotherapy, and targeted agents within standardized treatment protocols.
Dr. Armando Santoro, MD
Specialization: Medical Oncology
Years of Experience: 30+ years
Dr. Armando Santoro works at Humanitas Research Hospital in Milan. His practice includes solid tumors such as breast and lung cancer. He is involved in clinical research evaluating new anticancer drugs and applies guideline-based treatment approaches in daily practice.
Dr. Saverio Cinieri, MD
Specialization: Medical Oncology
Years of Experience: 25+ years
Dr. Saverio Cinieri is associated with Ospedale Perrino in Brindisi. His expertise includes breast cancer and systemic oncologic therapies. He contributes to national oncology discussions and focuses on personalized treatment strategies based on tumor characteristics.
Dr. Francesco Lo-Coco, MD
Specialization: Hematology
Years of Experience: 30+ years
Dr. Francesco Lo-Coco was affiliated with University Campus Bio-Medico in Rome. He was recognized for his work in acute promyelocytic leukemia and risk-adapted treatment models. His clinical contributions emphasized careful monitoring, standardized protocols, and patient safety in hematologic oncology care.
| Consultation Type | Estimated Cost Range |
| Hematologists-Oncologists consultation | $250–$450 |
Note: Costs are approximate and provided for general guidance only. Prices vary by healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Choosing a hematologist-oncologist in another country can feel complex. You may be balancing medical urgency, financial considerations, and the need for clear communication. It is important to review credentials, hospital standards, and support systems carefully before making decisions.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient-safety protocols, and informed consent practices
Foreign patients should also consider practical factors. Visa or entry requirements depend on your nationality and length of stay. For certain treatments, a postoperative or observation stay of at least 7–14 days may be necessary, depending on the clinical situation. While major cities often provide English-language support, smaller centers may have limited non-Italian communication. Planning follow-up care with a physician in your home country is important for continuity of treatment and monitoring.
Patients considering Hematologists-Oncologists care in Italy can share their medical reports with Best Clinic Abroad to receive coordinated support, guidance on consultation options, and a structured starting point for treatment planning.
Do I need a medical visa to travel to Italy for hematology or oncology treatment?
Visa requirements depend on your nationality and the expected duration of your stay. Many non-EU patients require a medical visa if treatment will extend beyond short-term travel allowances. You may need an official appointment letter from the hospital and documentation outlining your planned care. It is advisable to contact the Italian consulate in your country for updated information and to begin the process early, as medical documentation is often required.
Will I find English-speaking hematologists-oncologists in Italy?
In many large academic hospitals and cancer centers, you can find hematologists-oncologists who speak English. Major institutions in cities such as Milan, Rome, and Bologna frequently treat international patients and may offer translation services. However, language availability can vary outside major urban centers. It is reasonable to confirm language support with the hospital before scheduling your consultation.
Can I arrange an online consultation before traveling to Italy?
Yes, you may arrange an online consultation through Best Clinic Abroad. This allows you to share your medical reports and discuss your condition with a specialist remotely before making travel decisions. An online consultation can help you understand potential diagnostic steps, estimated timelines, and whether travel for further evaluation is appropriate. Final treatment recommendations are typically made after a full clinical assessment.
How long should I plan to stay in Italy for cancer or blood disorder treatment?
The duration of stay depends on your diagnosis, the type of therapy required, and how your body responds to treatment. Some patients may travel for an initial specialist consultation and return home for therapy. Others may require several weeks for chemotherapy cycles, stem cell transplantation, or close monitoring. Your treating team will provide a timeline based on your individual clinical plan.
Are Italian cancer centers accredited and regulated?
Italy’s healthcare system operates under national regulations overseen by the Ministry of Health. Many oncology and hematology departments are part of university hospitals or recognized research institutes. These centers typically follow European clinical guidelines and participate in quality assurance programs. You may request information about hospital accreditation, multidisciplinary tumor boards, and patient safety protocols before confirming treatment plans.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.